Information
-
Trademark
-
98123490
-
International Classifications
-
Filing Date
August 09, 2023
a year ago
-
Transaction Date
July 13, 2024
4 months ago
-
Status Date
April 17, 2024
7 months ago
-
Location Date
April 17, 2024
7 months ago
-
First Use Anywhere Date
September 01, 2014
10 years ago
-
First Use In Commerce Date
September 01, 2014
10 years ago
-
Status Code
641
-
Current Location
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
Employee Name
LEASER, ANDREW C
-
Attorney Name
William R. Samuels
Law Office Assigned Location Code
M80
-
Owners
Case File Statements
- DM0000: The mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside.
- GS0051: Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
- CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
-
9/7/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/12/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
9/8/2023 - a year ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
4/10/2024 - 7 months ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/12/2024 - 4 months ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/17/2024 - 7 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/17/2024 - 7 months ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/17/2024 - 7 months ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
